These financial adviser fees pinch your portfolio — and 2 questions can stop them
From revenue-sharing ‘kickbacks’ to interest on idle cash, hidden costs may be eroding your returns.
Access Denied
Access Denied You don’t have permission to access ” on this server. Reference #18.162c1102.1777769250.191eddf0
‘We’re all worried the honey pot will run dry’: Does the U.S. government borrow from my Social Security to fund federal programs?
There are many suggestions floating around Washington D.C. on how to fix the program’s imminent funding issues.
FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies
If that proposal is finalized, the exclusion would likely limit the mass compounding of those medicines unless they appear on the FDA’s drug shortage list.
Hershey says GLP-1s are driving higher gum and mint sales
Sales of Hershey’s Ice Breakers rose 8% in the first quarter, thanks to the trend.
Spirit Airlines made this critical mistake that drove its demise
Spirit has canceled all future flights and is immediately shutting down.
Weight loss and hair loss: The growing hair treatment market from GLP-1s
A common side effect of many GLP-1 drugs is hair loss. It’s creating a formerly untapped but growing market for hair treatment products.
‘There is an imbalance of power’: My husband has cancer. Why must we wait two hours for a 10-minute CT scan?
“This letter is in memory of all the patients who died waiting for their medical appointments to begin.”
Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket
Lilly hiked its full-year sales outlook by $2 billion, and also raised its adjusted profit guidance.
Why you won't find Kentucky Derby bets on prediction platforms
The Kentucky Derby takes place Saturday in Louisville. Prediction market platforms like Kalshi and Polymarket are sitting the race out.
